|Title:||president & CEO|
|Executive Summary:||CogniScent Inc. has developed a core biomimetic sensing platform (ScenTraK) capable of sensing many toxic chemicals and expolosive compounds , in real time, with high sensitivity, over a range of conditions. It can achieve this at 25% of the cost of current trace detection technologies. This platform is configured in a handheld device at a cost that allows the use of multiple devices which increases the efficiency of the user by setting perimeters, getting statistically relevant data through multiple continuous sampling and having a high probability of detection. CogniScent’s patented technology adds value through improving the level of safety and efficiency of first responders as well as ensuring a safe clean environment for the public.
CogniScent has developed products for the detection of methamphetamine labs and for rapid identification of commonly transported toxic chemicals. It is looking for marketing partners and resources with which to launch these products onto the market. Its business model is to be an OEM supplier of sensing hardware for incorporation into the partners branded product.